| Dolutegravir Pediatric Liquid Formulation Study (NCT03921723) | ViiV Healthcare | 2019-05-07 |
| Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso (NCT03896724) | University of Oxford | 2019-05-07 |
| Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation (NCT03925935) | Angiocrine Bioscience | 2019-05-07 |
| Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant (NCT03862833) | Nantes University Hospital | 2019-05-07 |
| A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma (NCT03914443) | National Cancer Center, Japan | 2019-05-07 |
| A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma (NCT03866239) | Hoffmann-La Roche | 2019-05-07 |
| Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray (NCT04146623) | Codagenix, Inc | 2019-05-07 |
| The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions. (NCT03951051) | Pharmtechnology LLC | 2019-05-06 |
| Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption (NCT04166786) | Parc de Salut Mar | 2019-05-06 |
| Image Guided Surgery in Sinonasal Inverted Papilloma (NCT03925285) | University Medical Center Groningen | 2019-05-06 |
| Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects (NCT04521192) | Jiangsu HengRui Medicine Co., Ltd. | 2019-05-06 |
| A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD) (NCT04875962) | UCB Biopharma S.P.R.L. | 2019-05-06 |
| A Study to Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects (NCT03954600) | Neuropore Therapies Inc. | 2019-05-05 |
| Injection of Tenoxicam Versus Arthrocentesis Alone in the Treatment of Temporomandibular Joint Osteoarthritis (NCT05497570) | Ataturk University | 2019-05-03 |
| A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers (NCT03892499) | Cyclerion Therapeutics | 2019-05-03 |
| Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome (NCT04062981) | SK Life Science, Inc. | 2019-05-03 |
| A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma (NCT03952078) | Corvus Pharmaceuticals, Inc. | 2019-05-03 |
| Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions (NCT03918551) | Pharmtechnology LLC | 2019-05-03 |
| Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno® (NCT03966365) | Laboratorios Sophia S.A de C.V. | 2019-05-02 |
| Study of ORIC-101 in Combination With Anticancer Therapy (NCT03928314) | ORIC Pharmaceuticals | 2019-05-02 |
| A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants (NCT03950960) | Bristol-Myers Squibb | 2019-05-02 |
| Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed) (NCT03927170) | GL Pharm Tech Corporation | 2019-05-02 |
| Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants (NCT03939702) | Bristol-Myers Squibb | 2019-05-02 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution (NCT04284514) | Aerpio Therapeutics | 2019-05-02 |
| Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients (NCT04013646) | Bundang CHA Hospital | 2019-05-02 |
| Sleep Disordered Breathing With Opioid Use (NCT05589753) | VA Office of Research and Development | 2019-05-02 |
| A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants (NCT03928327) | Millennium Pharmaceuticals, Inc. | 2019-05-02 |
| TCR-engineered T Cells in Solid Tumors: IMA202-101 (NCT03441100) | Immatics US, Inc. | 2019-05-02 |
| The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers (NCT03645408) | Boston Medical Center | 2019-05-02 |
| Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy (NCT03936894) | Children's National Research Institute | 2019-05-01 |
| Adoptive Transfer of Haploidentical NK Cells and N-803 (NCT03899480) | University of Minnesota | 2019-05-01 |
| Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer (NCT03892642) | University of Oklahoma | 2019-05-01 |
| Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT04012879) | Chinese PLA General Hospital | 2019-05-01 |
| Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia (NCT03599375) | jiuwei cui | 2019-05-01 |
| A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors (NCT03926013) | Janssen Research & Development, LLC | 2019-05-01 |
| Effect of Adding Midazolam Versus Fentanyl to Intrathecal Levobupivacaine in Patients Undergoing Caesarean Section (NCT03824314) | Mohamed Abdelrady Mohamed | 2019-05-01 |
| Awake Thoracic Epidural Anaesthesia Versus General Anesthesia for Video Assisted Thoracoscopic Surgery (NCT03902470) | Assiut University | 2019-05-01 |
| Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects (NCT03949426) | Kangpu Biopharmaceuticals, Ltd. | 2019-05-01 |
| Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers (NCT03730311) | Viriom | 2019-05-01 |
| Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease (NCT03808103) | Intralytix, Inc. | 2019-05-01 |
| The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II (NCT03947879) | Hawaii Pacific Health | 2019-05-01 |
| IVIG-eye Drops Treatment for Dry Eye Disease (NCT03992482) | Sandeep Jain, MD | 2019-05-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants (NCT03933488) | Takeda | 2019-05-01 |
| Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant (NCT03966209) | Shanghai Zhongshan Hospital | 2019-05-01 |
| Improve Checkpoint-blockade Response in Advanced Urothelial Cancer (NCT03871036) | The Netherlands Cancer Institute | 2019-05-01 |
| The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients (NCT03877679) | Cairo University | 2019-05-01 |
| Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (NCT03939026) | Allogene Therapeutics | 2019-05-01 |
| Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors (NCT03905148) | BeiGene | 2019-05-01 |
| Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma (NCT03528642) | National Cancer Institute (NCI) | 2019-05-01 |
| Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer (NCT03829930) | George Washington University | 2019-05-01 |
| SOX-based CRT for Esophageal Cancer. (NCT03991104) | Zhejiang Provincial People's Hospital | 2019-05-01 |
| Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM (NCT03940833) | Asclepius Technology Company Group (Suzhou) Co., Ltd. | 2019-05-01 |
| Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation (NCT03843528) | Johns Hopkins All Children's Hospital | 2019-05-01 |
| Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165 (NCT03930602) | Bristol-Myers Squibb | 2019-05-01 |
| MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma (NCT03932955) | Peking University | 2019-05-01 |
| Radiolabelled IV and Oral Metabolism Study of F901318 (NCT02912026) | F2G Ltd | 2019-05-01 |
| A Study to Evaluate ALN-AGT01 in Patients With Hypertension (NCT03934307) | Alnylam Pharmaceuticals | 2019-05-01 |
| Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Non-Hodgkin Lymphoma (NCT04012892) | Chinese PLA General Hospital | 2019-05-01 |
| Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca (NCT03919292) | Virginia Commonwealth University | 2019-05-01 |
| Evaluation of the Pharmacokinetics, Safety and Effects of NutriterraTM in Healthy Adults (NCT03937206) | Nuseed Americas Inc. | 2019-05-01 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
| Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions (NCT05090449) | Laboratorios Silanes S.A. de C.V. | 2019-05-01 |
| Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A (NCT03950297) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2019-05-01 |
| Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor (NCT03931720) | Asclepius Technology Company Group (Suzhou) Co., Ltd. | 2019-05-01 |
| Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC (NCT03813394) | National University Hospital, Singapore | 2019-05-01 |
| Cannabidiol, Morphine, Pain (NCT04030442) | Wayne State University | 2019-05-01 |
| Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression (NCT03833063) | Helse Stavanger HF | 2019-05-01 |
| High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03908333) | Medical College of Wisconsin | 2019-05-01 |
| Quadratus Lumborum Nerve Blocks for Myomectomies (NCT03935815) | University of California, Los Angeles | 2019-05-01 |
| A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699 (NCT03953092) | Youngene Therapeutics Inc., Ltd. | 2019-05-01 |
| Analgesic Efficacy of Fascia Iliaca Compartment Block (NCT03957499) | Samaa Rashwan | 2019-05-01 |
| Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer (NCT03941457) | Asclepius Technology Company Group (Suzhou) Co., Ltd. | 2019-05-01 |
| A Study of Different Injectable Formulations of LY3375880 in Healthy Participants (NCT03913260) | Eli Lilly and Company | 2019-05-01 |
| Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors (NCT03940820) | Asclepius Technology Company Group (Suzhou) Co., Ltd. | 2019-05-01 |
| Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections (NCT03802552) | University of Colorado, Denver | 2019-05-01 |
| A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. (NCT03752294) | University of Rhode Island | 2019-05-01 |
| Thoracic Paravertebral Block Versus IV Fentanyl Infusion (NCT03903367) | Beni-Suef University | 2019-05-01 |
| A Safety and Tolerability Study of JNJ-72537634 in Healthy Participants (NCT03931447) | Janssen Research & Development, LLC | 2019-04-30 |
| Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in Volunteers (NCT03948451) | AstraZeneca | 2019-04-30 |
| Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer (NCT03166254) | Washington University School of Medicine | 2019-04-30 |
| Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression (NCT04301895) | University of California, San Francisco | 2019-04-30 |
| Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia (NCT03663881) | Hospital Universitario San Ignacio | 2019-04-30 |
| Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT03907527) | Precigen, Inc | 2019-04-30 |
| A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants (NCT03580824) | University of Oxford | 2019-04-30 |
| Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers (NCT03912831) | Gilead Sciences | 2019-04-30 |
| Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects (NCT03874234) | GlaxoSmithKline | 2019-04-30 |
| Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer (NCT04012619) | Sichuan University | 2019-04-30 |
| Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas (NCT03478462) | Cellectar Biosciences, Inc. | 2019-04-30 |
| A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas (NCT03893682) | Aptose Biosciences Inc. | 2019-04-30 |
| A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers (NCT03936166) | Crinetics Pharmaceuticals Inc. | 2019-04-29 |
| Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03586661) | M.D. Anderson Cancer Center | 2019-04-29 |
| Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NCT03985189) | Kyowa Kirin Co., Ltd. | 2019-04-29 |
| Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for Injection (NCT04116840) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2019-04-29 |
| Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004) (NCT03873038) | Merck Sharp & Dohme LLC | 2019-04-29 |
| A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease (NCT03913000) | Idorsia Pharmaceuticals Ltd. | 2019-04-29 |
| Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects (NCT04467203) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-04-28 |
| A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors (NCT03871855) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-28 |
| Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects (NCT03909451) | Sanofi | 2019-04-28 |
| Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors (NCT03908814) | Dragonboat Biopharmaceutical Company Limited | 2019-04-27 |
| Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma (NCT03867370) | Shanghai Junshi Bioscience Co., Ltd. | 2019-04-26 |